Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -93.74% is 35% above its 5-year average of -144.66%, near the high end of its 5-year range (-621.22%–-29.93%).
As of the fiscal period ended Monday, June 30, 2025. 33.76% above its 12-month average of -141.52%.
Reported quarterly profit margin; no daily interpolation.
NET PROFIT MARGIN
-93.74%
NET PROFIT MARGIN AVG TTM
-141.52%
NET PROFIT MARGIN AVG 3Y
-132.99%
NET PROFIT MARGIN AVG 5Y
-110.03%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+33.76%
CURRENT VS 3Y AVG
+29.51%
CURRENT VS 5Y AVG
+14.80%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
9.05%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
-1135.81%
vs the sector median at left
23andMe Holding Co.
Market Cap
$15.31M
Net Profit Margin
-93.74%
TTM Avg
-141.52%
3Y Avg
-132.99%
5Y Avg
-110.03%
Market Cap
$471.59M
Net Profit Margin
-81.78%
TTM Avg
-67.34%
3Y Avg
-66.78%
5Y Avg
-66.78%
Market Cap
$1.21B
Net Profit Margin
-7.13%
TTM Avg
-23.45%
3Y Avg
-155.72%
5Y Avg
-114.72%
Market Cap
$2.64B
Net Profit Margin
27.04%
TTM Avg
19.73%
3Y Avg
-2.42%
5Y Avg
-44.65%
Market Cap
$2.68B
Net Profit Margin
-17.06%
TTM Avg
-20.12%
3Y Avg
-16.95%
5Y Avg
-10.04%
Market Cap
$6.19B
Net Profit Margin
-0.56%
TTM Avg
7.00%
3Y Avg
-0.29%
5Y Avg
-8.82%
Market Cap
$7.69B
Net Profit Margin
-17.77%
TTM Avg
-60.53%
3Y Avg
-62.93%
5Y Avg
-77.31%
Market Cap
$8.09B
Net Profit Margin
-0.30%
TTM Avg
-1.75%
3Y Avg
-5.71%
5Y Avg
-20.27%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| 23andMe Holding Co. (ME) | $15.31M | -93.74% | -141.52% | -132.99% | -110.03% |
| NRC Health (NRC)vs › | $439.69M | 4.18% | 12.88% | 16.89% | 20.14% |
| Shoulder Innovations, Inc. (SI)vs › | $471.59M | -81.78% | -67.34% | -66.78% | -66.78% |
| Teladoc Health, Inc. (TDOC)vs › | $1.21B | -7.13% | -23.45% | -155.72% | -114.72% |
| TransMedics Group, Inc. (TMDX)vs › | $2.64B | 27.04% | 19.73% | -2.42% | -44.65% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.68B | -17.06% | -20.12% | -16.95% | -10.04% |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.19B | -0.56% | 7.00% | -0.29% | -8.82% |
| Tempus AI, Inc. (TEM)vs › | $7.69B | -17.77% | -60.53% | -62.93% | -77.31% |
| Oscar Health, Inc. (OSCR)vs › | $8.09B | -0.30% | -1.75% | -5.71% | -20.27% |
| Bio-Rad Laboratories, Inc. (BIO)vs › | $8.80B | 6.52% | -21.22% | -48.94% | 16.61% |
Operating Margin
-126.7%
Net Profit Margin
-93.7%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2025-06-30 | -93.74% |
| 2025-03-31 | -220.04% |
| 2024-12-31 | -88.01% |
| 2024-09-30 | -134.11% |
| 2024-06-30 | -171.72% |
| 2024-03-31 | -326.16% |
| 2023-12-31 | -621.22% |
| 2023-09-30 | -150.54% |
| 2023-06-30 | -171.90% |
| 2023-03-31 | -69.39% |
| 2022-12-31 | -137.38% |
| 2022-09-30 | -87.32% |
| 2022-06-30 | -138.78% |
| 2022-03-31 | -69.16% |
| 2021-12-31 | -157.14% |
| 2021-09-30 | -29.93% |
| 2021-06-30 | -70.94% |
| 2021-03-31 | -75.65% |
| 2020-12-31 | -80.47% |
| 2020-09-30 | -69.86% |
| 2020-06-30 | -74.43% |
